- This event has passed.
Webinar: Implementing a Bedaquiline-Based, Injectable-Free Regimen for Drug-Resistant Tuberculosis
August 16 @ 10:00 am - 12:00 pm
Treatment Action Group (TAG), The Global Tuberculosis Community Advisory Board (TB CAB), and the Drug Resistant-TB Scale-Up Treatment Action Team (DR-TB STAT)
10:00 AM ET
TAG, TB CAB, and DR-TB STAT invite you to a webinar on Implementing a bedaquiline-based, injectable-free regimen for drug-resistant tuberculosis (DR-TB) in light of the new WHO policy brief on DR-TB regimens.
Dr. Nobert Ndjeka from the National Department of Health in South Africa will be talking about the South African experience as the first country to roll out this unique and less toxic regimen and how the South Africa regimen differs from the new WHO policy brief on DR-TB regimens (including advantages and disadvantages).
Eunice Omesa, the Section Head for Monitoring, Evaluation & Research from the Ministry of Health in Kenya will be talking about practical considerations countries have in order to implement a bedaquiline-based, injectable-free regimen bearing in mind the new WHO policy brief on DR-TB regimens.
We’ll also include perspectives from a survivor of drug-resistant TB, and other members of civil society. TB survivor and TB PROOF management committee member Phumeza Tisile will share her experience with injectable drug-induced hearing loss and recommendations for national programs. The discussion will be moderated by Marcus Low, Spotlight editor and technical co-lead of the Global TB Community Advisory Board.